Roller coasters – cause “Chronic Headache?
Startling findings reveal that the highly popular roller coaster rides that are invading all our amusement parks may not be safe after all! A kind of posttraumatic migraine might be induced on account the seemingly safe rides. In a specific incident that was studied by researchers, following one such ride a young lady presented with throbbing headache, blurred vision and nausea, immediatel...TIZANIDINE - New solution to chronic headache
Chronic headache is one of the common neurological problems affecting greater amount of population. Most are not due to any underlying disease. If you happen to be one of the unfortunates suffering from this chronic migraine, then there is a reason to celebrate. Yes, the drug used to treat muscle spasms may provide new hope for millions of people who suffer from frequent headaches. Ameri...Analgesic abuse - cause for chronic headache in children
Over the counter pain medications such as aspirin, acetaminophen(paracetamol) etc., is now identified to be the cause of chronic headache in children. A team of Israeli researchers who treated 26 adolescents, found that the average number of tablets taken by each patient was 28 each week, with 16 using pain medication daily. They stopped all the analgesic medications and found that the h...Hormone replacement Therapy a headache
Researchers from Sweden warn women undergoing hormone replacement therapy against the risk of uterus cancer. Hormone Replacement Therapy is advised for women to reduce menopausal side effects like hot flushes and night sweats, and to protect them from osteoporosis and heart disease.// Research has shown the drugs, which replace natural hormones that decrease with menopause,...ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at American Headache Society Meeting
MONTGOMERY, Ala.--(BUSINESS WIRE)--Jun 8, 2007 - ProEthicPharmaceuticals, Inc., a privately funded specialty pharmaceuticalcompany that acquires, develops, licenses, and markets nicheprescription products, today presented detailed Phase III studydata for PRO-513, the Company's product candidate for the treatmentof migraine headaches. The results were presented in two posterpresentations at...